Does tacrolimus offer virtual freedom from chronic rejection after primary liver transplantation? Risk and prognostic factors in 1,048 liver transplantations with a mean follow-up of 6 years.

Jain, A

Does tacrolimus offer virtual freedom from chronic rejection after primary liver transplantation? Risk and prognostic factors in 1,048 liver transplantations with a mean follow-up of 6 years. [electronic resource] - Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society Jul 2001 - 623-30 p. digital

Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.

1527-6465

10.1053/jlts.2001.25364 doi


Adult
Follow-Up Studies
Graft Rejection--immunology
Humans
Immunosuppressive Agents--therapeutic use
Liver Transplantation--immunology
Prognosis
Risk Factors
Tacrolimus--therapeutic use